... Homero, Plinio el Viejo, Esquilo, Lucrecio, Diodoro de Sicilia, Ciceron, Horacio, Vi...
Tópico(s): Spanish Culture and Identity
2020 - | Anabases
María Chaparro, Diana Acosta, Cristina Rodríguez, Francisco Mesonero, M Vicuña, Manuel Barreiro‐de Acosta, A Fernández-Clotet, Álvaro Hernández Martínez, M Arroyo, Isabel Vera, Alexandra Ruiz‐Cerulla, Beatriz Sicilia, M J Cabello Tapia, Carmen Muñoz Villafranca, Jesús Castro‐Poceiro, J Martínez Cadilla, Mónica Sierra‐Ausín, Juan María Vázquez Morón, Raquel Vicente Lidón, Fernando Bermejo, Vanesa Royo, Margalida Calafat, Carlos González‐Muñoza, Eduardo Leo Carnerero, Noemí Manceñido, Leyanira Torrealba, Horacio Alonso‐Galán, J M Benítez, Yolanda Ber, M T Diz-Lois Palomares, María José García, José Fernando Muñoz, Edisa María Armesto González, Xavier Calvet, Alejandro Hernández-Camba, Rosa Eva Madrigal Domínguez, Luís Menchén, J L Pérez Calle, Marta Piqueras, Carmen Dueñas Sadornil, Belén Botella, Teresa Martínez-Pérez, Laura Ramos, M C Rodríguez-Grau, Elena San Miguel, José Luis Fernández Forcelledo, Paola María Fradejas Salazar, Marifé García-Sepulcre, Ana Gutiérrez, Jordina Llaó, Eva Sesé Abizanda, Marta Maia Boscá-Watts, Eduardo Iyo, Alma Keco‐Huerga, Carmen Martínez Bonil, Elena Peña González, Pablo Pérez‐Galindo, Pilar Varela, Javier P. Gisbert,
INTRODUCTION: The objective of this study was to assess the durability, short-term and long-term effectiveness, and safety of tofacitinib in ulcerative colitis (UC) in clinical practice. METHODS: This is a retrospective multicenter study including patients with UC who had received the first tofacitinib dose at least 8 weeks before the inclusion. Clinical effectiveness was based on partial Mayo score. RESULTS: A total of 408 patients were included. Of them, 184 (45%) withdrew tofacitinib during follow- ...
Tópico(s): Chronic Lymphocytic Leukemia Research
2022 - Lippincott Williams & Wilkins | The American Journal of Gastroenterology
María Chaparro, Sandra Hermida, Diana Acosta, A Fernández-Clotet, Manuel Barreiro‐de Acosta, Álvaro Hernández Martínez, M Arroyo, Marta Maia Boscá-Watts, María Teresa Diz-Lois Palomares, Luís Menchén, J Martínez Cadilla, Eduardo Leo‐Carnerero, Carmen Muñoz Villafranca, Mónica Sierra‐Ausín, Yago González‐Lama, Sabino Riestra, Pau Sendra Rumbeu, M J Cabello Tapia, Irene García de la Filia, Raquel Vicente, Daniel Ceballos, Ramón Pajares, Patricia Ramírez de la Piscina, María Dolores Martín‐Arranz, Laura Ramos, Alexandra Ruiz‐Cerulla, Teresa Martínez-Pérez, Elena San Miguel Amelivia, Xavier Calvet, José María Huguet, Alma Keco‐Huerga, R H Lorente Poyatos, José Fernando Muñoz, Ángel Ponferrada, Beatriz Sicilia, Pedro Delgado‐Guillena, Elena Gómez Delgado, Francisco J. Rancel‐Medina, Horacio Alonso‐Galán, Belén Herreros, Montserrat Rivero, Pilar Varela, Fernando Bermejo, Marifé García Sepulcre, Leticia Gimeno‐Pitarch, Lilyan Kolle‐Casso, Lucía Márquez, Pilar Martínez Tirado, C Castellanos Ramirez, Eva Sesé Abizanda, Carmen Dueñas Sadornil, Hipólito Fernández Rosáenz, Ana Gutiérrez, Rosa Eva Madrigal Domínguez, Óscar Nantes, Yolanda Ber, Belén Botella Mateu, Santiago Frago Larramona, Pilar López Serrano, José María Rubio Mateos, Sandra Torrá Alsina, Eduardo Iyo, José Luis Fernández Forcelledo, Luis Hernández, M C Rodríguez-Grau, David Monfort Miquel, Manuel Van Domselaar, Carmen López Ramos, M. Barcia, Javier P. Gisbert,
Summary Background Ustekinumab is approved for ulcerative colitis (UC). Aims To assess the durability of ustekinumab in patients with UC and its short‐term effectiveness, durability and tolerability in clinical practice. Methods Retrospective, multicentre study of patients who had received their first ustekinumab dose at least 16 weeks before inclusion. Patients were followed until treatment discontinuation or last visit. Only patients with active disease at the start of ustekinumab treatment were ...
Tópico(s): Chronic Lymphocytic Leukemia Research
2024 - Wiley | Alimentary Pharmacology & Therapeutics
María Chaparro, Ana Garre, Andrea Núñez Ortiz, M T Diz-Lois Palomares, Cristina Rodríguez, Sabino Riestra, Milagros Vela, J M Benítez, Estela Fernández Salgado, Eugenia Sánchez Rodríguez, Vicent Hernández, R Ferreiro-Iglesias, Ángel Ponferrada Díaz, Jesús Barrio, José María Huguet, Beatriz Sicilia, María Dolores Martín‐Arranz, Xavier Calvet, Daniel Ginard, Inmaculada Alonso-Abreu, Luís Fernández-Salazar, Pilar Varela Trastoy, Montserrat Rivero, Isabel Vera-Mendoza, Pablo Vega, Pablo Navarro, Mónica Sierra, José Luis Cabriada, Mariam Aguas, Raquel Vicente, Mercè Navarro-Llavat, Ana Echarri, Fernando Gomollón, Elena Guerra del Río, Concepción Piñero, María José Casanova, Kateřina Špičáková, Jone Ortiz de Zárate, Emilio Torrella Cortés, Ana Gutiérrez, Horacio Alonso‐Galán, Álvaro Hernández-Martínez, José Miguel Marrero, Rufo Lorente Poyatos, Margalida Calafat, Lidia Martí Romero, Pilar Robledo, Orencio Bosch, Nuria Jiménez, María Esteve, José María Duque, Ana Fuentes Coronel, Manuela Josefa Sampedro, Eva Sesé Abizanda, Belén Herreros Martínez, Liliana Pozzati, Hipólito Fernández Rosáenz, Belén Crespo Suarez, Pilar López Serrano, Alfredo J. Lucendo, Margarita Muñoz Vicente, Fernando Bermejo, José Ramírez Palanca, Margarita Menacho, Amalia Carmona, Raquel Camargo, Sandra Torrá Alsina, Nuria Maroto, Juan Nerín de la Puerta, Elena Castro, Ignacio Marín‐Jiménez, Belén Botella, Amparo Sapiña, Noelia Cruz, José Luis Fernández Forcelledo, Abdel Bouhmidi, Carlos Castańo-Milla, Verónica Opio, Isabel Nicolás, Marcos Kutz, A. Abraldes Bechiarelli, Jordi Gordillo, Yolanda Ber, Yolanda Torres Domínguez, M. Novella Durán, Silvia Rodríguez Mondéjar, Francisco J. Martínez-Cerezo, Lilyan Kolle, M Sàbat, César Ledezma, Eduardo Iyo, Óscar Roncero, Rebeca Irisarri, Laia Lluis, Isabel Blázquez Gómez, Eva Zapata, María José Fernández Alcalá, Cristina Martínez Pascual, María Montealegre, Laura Mata, Ana Monrobel, Alejandro Hernández-Camba, Luis Hernández, Marı́a Jesús Gómez de Tejada, Alberto Mir, María Luisa Galve, Marta Soler, Daniel Hervías, José Antonio Gómez-Valero, Manuel Barreiro‐de Acosta, Fernando Rodríguez‐Artalejo, Esther García‐Esquinas, Javier P. Gisbert,
(1) Aims: To assess the incidence of inflammatory bowel disease (IBD) in Spain, to describe the main epidemiological and clinical characteristics at diagnosis and the evolution of the disease, and to explore the use of drug treatments. (2) Methods: Prospective, population-based nationwide registry. Adult patients diagnosed with IBD-Crohn's disease (CD), ulcerative colitis (UC) or IBD unclassified (IBD-U)-during 2017 in Spain were included and were followed-up for 1 year. (3) Results: We identified 3611 ...
Tópico(s): Pregnancy and Medication Impact
2021 - Multidisciplinary Digital Publishing Institute | Journal of Clinical Medicine
Yamile Zabana, Ignacio Marín‐Jiménez, Iago Rodríguez‐Lago, Isabel Vera, María Dolores Martín‐Arranz, Iván Guerra, Javier P. Gisbert, Francisco Mesonero, Olga Benítez, Carlos Taxonera, Ángel Ponferrada-Díaz, Marta Piqueras, Alfredo J. Lucendo, Berta Caballol, Míriam Mañosa, Pilar Martínez-Montiel, Marta Maia Boscá-Watts, Jordi Gordillo, Luís Bujanda, Noemí Manceñido, Teresa Martínez-Pérez, Alicia López, Cristina Rodríguez-Gutiérrez, Santiago García‐López, Pablo Vega, Montserrat Rivero, Luigi Melcarne, María Calvo Íñiguez, Marisa Iborra, Manuel Barreiro‐de Acosta, Beatriz Sicilia, Jesús Barrio, José Lázaro Pérez, David Busquets, Isabel Pérez‐Martínez, Mercè Navarro-Llavat, Vicent Hernández, Federico Argüelles‐Arias, Fernando Ramírez Esteso, Susana Meijide, Laura Ramos, Fernando Gomollón, Fernando Muñoz, Gerard Surís, Jone Ortiz de Zárate, José María Huguet, Jordina Llaó, Mariana Fe García-Sepulcre, Mónica Sierra, Miguel Durá-Gil, Sandra Estrecha, Ana Fuentes Coronel, Esther Hinojosa, Lorenzo Olivan, Eva Iglesias, Ana Gutiérrez, Pilar Varela, Núria Rull, Pau Gilabert, Alejandro Hernández-Camba, Alicia Brotons, Daniel Ginard, Eva Sesé, Daniel Carpio, Montserrat Aceituno, José Luis Cabriada, Yago González‐Lama, Laura Jiménez, María Chaparro, Antonio López-San Román, Cristina Alba, Rocío Plaza, Raquel Mena, Sonsoles Tamarit‐Sebastián, Elena Ricart, Margalida Calafat, Sonsoles Olivares, Pablo Navarro, Federico Bertoletti, Horacio Alonso‐Galán, Ramón Pajares, Pablo Olcina Domínguez, Pamela Manzano, Eugeni Domènech, María Esteve,
We aim to describe the incidence and source of contagion of COVID-19 in patients with IBD, as well as the risk factors for a severe course and long-term sequelae. This is a prospective observational study of IBD and COVID-19 included in the ENEIDA registry (53,682 from 73 centres) between March-July 2020 followed-up for 12 months. Results were compared with data of the general population (National Centre of Epidemiology and Catalonia). A total of 482 patients with COVID-19 were identified. Twenty- ...
Tópico(s): COVID-19 Clinical Research Studies
2022 - Multidisciplinary Digital Publishing Institute | Journal of Clinical Medicine
María Chaparro, Santiago Reinoso Hermida, Diana Acosta, A Fernández-Clotet, Manuel Barreiro‐de Acosta, Álvaro Hernández Martínez, M Arroyo, Marta Maia Boscá-Watts, M T Diz-Lois Palomares, Luís Menchén, J Martínez Cadilla, Eduardo Leo‐Carnerero, Carmen Muñoz Villafranca, Mónica Sierra‐Ausín, Yanira González, Sabino Riestra, Pau Sendra Rumbeu, M J Cabello Tapia, Irene García de la Filia, E Montil Miguel, Daniel Ceballos, Ramón Pajares Villarroya, Patricia Ramírez de la Piscina, María Dolores Martín‐Arranz, Laura Ramos, Alexandra Ruiz‐Cerulla, M P Teresa de Jesús, Eduardo San Miguel, Xavier Calvet, José María Huguet, Alma Keco‐Huerga, R H Lorente Poyatos, J F Muñoz, Ángel Ponferrada, Beatriz Sicilia, Pedro Delgado‐Guillena, Elvira Delgado, Francisco J. Rancel‐Medina, Horacio Alonso‐Galán, Javier P. Gisbert,
Abstract Background Primary aim: To assess the durability of ustekinumab treatment in patients with ulcerative colitis (UC). Secondary aims: To assess the short-term effectiveness, the durability of response, and the tolerability of ustekinumab in clinical practice. Methods Retrospective, multicenter study including UC patients who had received the 1st ustekinumab dose at least 16 weeks before inclusion. Patients were followed-up from the 1st ustekinumab dose to treatment discontinuation or last ...
Tópico(s): Chronic Lymphocytic Leukemia Research
2024 - Oxford University Press | Journal of Crohn s and Colitis
C J Suarez Ferrer, Francisco Mesonero, Berta Caballol, María Pilar Ballester, Iria Bastón‐Rey, Andrés Castaño García, José Miranda Bautista, R Saiz Chumillas, J M Benítez, L Sanchez Delgado, Alicia López‐García, Cristina Rubín de Célix, A Lopez Sanroma, María Dolores Martín‐Arranz, A Fernández-Clotet, Víctor Merino Murgui, Cristina Suárez, P. Florez, M E Lobato Matilla, Beatriz Sicilia, Pilar Soto Escribano, C Maroto Martin, Inmaculada Alonso Abreu, Luigi Melcarne, Rocío Plaza Santos, M Marques Cami, Antonio M.� Caballero-Mateos, C Gómez Díez, Margalida Calafat, Horacio Alonso Galán, Pablo Vega, B Castro Senosiain, Andrea Guerro Moya, C. Díaz, Kateřina Špičáková, Noemí Manceñido, Gemma María Muñoz‐Molina, Luisa de Castro, M Mañosa Círia, Manuel Barreiro‐de Acosta,
Abstract Background The most feared adverse events related to biological treatment in patients with inflammatory bowel disease (IBD) are the development of tumors and / or serious infections. These events are generally more frequent in elderly patients, so the increased use of biological drugs in these patients today makes it necessary to assess the safety of these drugs in this population. Methods Patients have been retrospectively included with established diagnosis of IBD at age, 65 at the time ...
Tópico(s): Cancer Immunotherapy and Biomarkers
2022 - Oxford University Press | Journal of Crohn s and Colitis
María Chaparro, Daisy Acosta, Cristina Rodríguez, M Vicuña, Francisco Mesonero, Manuel Barreiro‐de Acosta, A Fernández-Clotet, Álvaro Hernández Martínez, M Arroyo, Isabel Vera Mendoza, Beatriz Sicilia, Carmen Muñoz Villafranca, Jesús Castro‐Poceiro, J Martínez Cadilla, Juan María Vázquez Morón, E Montil, Mónica Sierra‐Ausín, Margalida Calafat, Eduardo Leo Carnerero, Noemí Manceñido, L Torrealba M, Horacio Alonso‐Galán, J M Benítez, Yolanda Ber, M J Cabello Tapia, M T Diz-Lois Palomares, María José García, Edisa María Armesto González, Xavier Calvet, Marta Piqueras, Carmen Dueñas Sadornil, J L Pérez Calle, Belén Botella, Teresa Martínez-Pérez, Laura Ramos, M C Rodríguez-Grau, José Luis Fernández Forcelledo, Ana Gutiérrez, Eva Sesé Abizanda, Javier P. Gisbert,
Abstract Background Main aim: To assess the retention rate of tofacitinib treatment in patients with ulcerative colitis (UC). Secondary aims: To assess the short-term effectiveness and the durability of response; to evaluate the evolution of extraintestinal manifestations (EIMs) and immunomediated inflammatory diseases (IMIDs); to assess the tolerability of tofacitinib in clinical practice. Methods Retrospective, multicenter study. UC patients who had received the first tofacitinib dose at least, 8 ...
Tópico(s): Systemic Lupus Erythematosus Research
2022 - Oxford University Press | Journal of Crohn s and Colitis
Yamile Zabana, Ignacio Marín‐Jiménez, Iago Rodríguez‐Lago, Isabel Vera, María Dolores Martín‐Arranz, Iván Guerra, Javier P. Gisbert, Francisco Mesonero, Olga Benítez, Carlos Taxonera, Ángel Ponferrada-Díaz, Marta Piqueras, Alfredo J. Lucendo, Berta Caballol, Míriam Mañosa, Pilar Martínez-Montiel, Marta Maia Boscá-Watts, Jordi Gordillo, Luís Bujanda, Noemí Manceñido, Teresa Martínez-Pérez, Alicia López, Cristina Rodríguez-Gutiérrez, Santiago García‐López, Pablo Vega, Montserrat Rivero, Luigi Melcarne, María Calvo Íñiguez, Marisa Iborra, Manuel Barreiro‐de Acosta, Beatriz Sicilia, Jesús Barrio, J L Pérez Calle, David Busquets, Isabel Pérez‐Martínez, Mercè Navarro-Llavat, Vicent Hernández, Federico Argüelles‐Arias, Fernando Ramírez Esteso, Susana Meijide, Laura Ramos, Fernando Gomollón, Fernando Muñoz, Gerard Surís, Jone Ortiz de Zárate, José María Huguet, Jordina Llaó, Mariana Fe García-Sepulcre, Mónica Sierra, Miguel Durá-Gil, Sandra Estrecha, Ana Fuentes Coronel, Esther Hinojosa, Lorenzo Olivan, Eva Iglesias, Ana Gutiérrez, Pilar Varela, Núria Rull, Pau Gilabert, Alejandro Hernández-Camba, Alicia Brotons, Daniel Ginard, Eva Sesé, Daniel Carpio, Montserrat Aceituno, José Luis Cabriada, Yago González‐Lama, Laura Jiménez, María Chaparro, Antonio López-San Román, Cristina Alba, Rocío Plaza, Raquel Mena, Sonsoles Tamarit‐Sebastián, Elena Ricart, Margalida Calafat, Sonsoles Olivares, Pablo Navarro, Federico Bertoletti, Horacio Alonso‐Galán, Ramón Pajares, Pablo Olcina Domínguez, Pamela Manzano, Eugeni Domènech, María Esteve,
(1) Scant information is available concerning the characteristics that may favour the acquisition of COVID-19 in patients with inflammatory bowel disease (IBD). Therefore, the aim of this study was to assess these differences between infected and noninfected patients with IBD. (2) This nationwide case−control study evaluated patients with inflammatory bowel disease with COVID-19 (cases) and without COVID-19 (controls) during the period March−July 2020 included in the ENEIDA of GETECCU. (3) A total of ...
Tópico(s): SARS-CoV-2 and COVID-19 Research
2022 - Multidisciplinary Digital Publishing Institute | Journal of Clinical Medicine
María Chaparro, Daisy Acosta, Cristina Rodríguez, Francisco Mesonero, M Vicuña, Manuel Barreiro‐de Acosta, A Fernández-Clotet, Álvaro Hernández Martínez, M Arroyo, Isabel Vera, Alexandra Ruiz‐Cerulla, B Sicilia, M J Cabello Tapia, Carmen Muñoz Villafranca, Jesús Castro‐Poceiro, J Martínez Cadilla, Mónica Sierra‐Ausín, Juan María Vázquez Morón, E Montil Miguel, F Bermejo, Virginia Matallana Royo, Margalida Calafat, Carlos González‐Muñoza, Eduardo Leo Carnerero, Noemí Manceñido, Leyanira Torrealba, Horacio Alonso‐Galán, J M Benítez, Yolanda Ber, M T Diz-Lois Palomares, María José García, J F Muñoz, Edisa María Armesto González, Xavier Calvet, Alejandro Hernández-Camba, Rosa Eva Madrigal Domínguez, Luís Menchén, J L Pérez Calle, Marta Piqueras, Javier P. Gisbert,
Abstract Background Main aim: To assess the durability of tofacitinib treatment in patients with ulcerative colitis (UC). Secondary aims: To assess the short and long-term effectiveness; the tolerability of tofacitinib in clinical practice; and to evaluate the evolution of extraintestinal manifestations (EIMs) and immunomediated inflammatory diseases (IMIDs). Methods Retrospective, multicenter study including UC patients who had received the first tofacitinib dose at least 8 weeks before the inclusion. ...
Tópico(s): Systemic Lupus Erythematosus Research
2023 - Oxford University Press | Journal of Crohn s and Colitis
Cristina Suárez Ferrer, Francisco Mesonero Gismero, Berta Caballol, María Pilar Ballester, Iria Bastón‐Rey, Andrés Castaño García, José Miranda Bautista, Rosa Saiz Chumillas, José M. Benítez, Laura Sanchez-Delgado, Alicia López García, Cristina Rubín de Célix, Inmaculada Alonso Abreu, Luigi Melcarne, Rocío Plaza Santos, M Marques Cami, Antonio M.� Caballero-Mateos, César Gómez Díez, Margalida Calafat, Horacio Alonso Galán, Pablo Vega Vilaamil, B Castro Senosiain, Andrea Guerro Moya, Carmen Yolanda Rodriguez Diaz, Kateřina Špičáková, Noemí Manceñido, Gema Molina, Luisa de Castro Parga, Andres Rodriguez Angulo, Lidia Cuevas del Campo, Maria del Carmen Rodriguez Grau, F.C Ramirez, Barbara Gomez Pastrana, I González Partida, Belén Botella Mateu, Elena Peña González, Eduardo Iyo, A Elosua Gonzalez, Empar Sainz Arnau, Luis Hernández, P Pérez Galindo, Leyanira Torrealba Medina, Sara Monsalve Alonso, Jose Antonio Olmos Perez, Carmen Dueñas Sadornil, Laura García Ramírez, María Dolores Martín‐Arranz, Antonio López Sanromán, A Fernández-Clotet, Víctor Merino Murgui, Cristina Suárez, P Flórez-Díez, M E Lobato Matilla, Beatriz Sicilia, Pilar Soto Escribano, Carlos Maroto Martin, Míriam Mañosa, Manuel Barreiro‐de Acosta,
INTRODUCTION: Biological therapies used for the treatment of inflammatory bowel disease (IBD) have shown to be effective and safe, although these results were obtained from studies involving mostly a young population, who are generally included in clinical trials. The aim of our study was to determine the efficacy and safety of the different biological treatments in the elderly population. METHODS: Multicenter study was carried out in the GETECCU group.Patients diagnosed with IBD and aged over 65 ...
Tópico(s): Celiac Disease Research and Management
2024 - Elsevier BV | Gastroenterología y Hepatología
Cristina Suárez Ferrer, Francisco Mesonero Gismero, Berta Caballol, María Pilar Ballester, Iria Bastón‐Rey, Andrés Castaño García, José Miranda Bautista, Rosa Saiz Chumillas, José M. Benítez, Laura Sanchez-Delgado, Alicia López García, Cristina Rubín de Célix, Inmaculada Alonso Abreu, Luigi Melcarne, Rocío Plaza Santos, M Marques Cami, Antonio M.� Caballero-Mateos, César Gómez Díez, Margalida Calafat, Horacio Alonso Galán, Pablo Vega Vilaamil, B Castro Senosiain, Andrea Guerro Moya, Carmen Yolanda Rodriguez Diaz, Kateřina Špičáková, Noemí Manceñido, Gema Molina, Luisa de Castro Parga, Andres Rodriguez Angulo, Lidia Cuevas del Campo, Maria del Carmen Rodriguez Grau, F.C Ramirez, Barbara Gomez Pastrana, I González Partida, Belén Botella Mateu, Elena Peña González, Eduardo Iyo, A Elosua Gonzalez, Empar Sainz Arnau, Luis Hernández, P Pérez Galindo, Leyanira Torrealba Medina, Sara Monsalve Alonso, Jose Antonio Olmos Perez, Carmen Dueñas Sadornil, Laura García Ramírez, María Dolores Martín‐Arranz, Antonio López Sanromán, A Fernández-Clotet, Víctor Merino Murgui, Cristina Suárez, P Flórez-Díez, M E Lobato Matilla, Beatriz Sicilia, Pilar Soto Escribano, Carlos Maroto Martin, Míriam Mañosa, Manuel Barreiro‐de Acosta,
Tópico(s): Celiac Disease Research and Management
2024 - Elsevier BV | Gastroenterología y Hepatología (English Edition)
C J Suarez Ferrer, Francisco Mesonero, Berta Caballol, R Saiz Chumillas, Iria Bastón‐Rey, Cristina Rubín de Célix, Luigi Melcarne, Antonio M.� Caballero-Mateos, Margalida Calafat, Horacio Alonso Galán, Pablo Vega, B Castro Senosiain, C. Díaz, Rocío Plaza Santos, M Marques Cami, Marina Grau, Fernando Fernández‐Ramírez, Alicia López‐García, B Gomez Pastrana, I González Partida, B Botella Mateu, Lyna Campo, E. Peña, Eduardo Iyo, A Elosua Gonzalez, Eduardo Sainz, L Arranz Hernández, P Pérez Galindo, J L Rueda García, María Dolores Martín‐Arranz, Antonio López Sanromán, A Fernández-Clotet, Beatriz Sicilia, Cristina Suárez, M Mañosa Círia, Manuel Barreiro‐de Acosta,
Abstract Background Biological drugs are being increasingly used for the treatment of inflammatory bowel diseases (IBD) in elderly patients. Despite the particular characteristics of this population subgroup, the efficacy and safety of these treatments in real clinical practice is poorly evaluated. Methods Retrospective and multicenter study of GETECCU, carried out in 28 Spanish hospitals. Patients with IBD who started biological treatment (Infliximab, Adalimumab, Golimumab, Ustekinumab or Vedolizumab) ...
Tópico(s): Pharmaceutical studies and practices
2021 - Oxford University Press | Journal of Crohn s and Colitis
María Chaparro, Ana Garre, Andrea Núñez Ortiz, María Teresa Diz-Lois Palomares, Cristina Rodríguez, Sabino Riestra, Milagros Vela, J M Benítez, Estela Fernández Salgado, Eugenia Sánchez Rodríguez, Vicent Hernández, R Ferreiro-Iglesias, Ángel Ponferrada Díaz, Jesús Barrio, José María Huguet, Beatriz Sicilia, María Dolores Martín‐Arranz, Xavier Calvet, Daniel Ginard, Inmaculada Alonso-Abreu, Luís Fernández-Salazar, Pilar Varela Trastoy, Montserrat Rivero, Isabel Vera-Mendoza, Pablo Vega, Pablo Navarro, Mónica Sierra, José Luis Cabriada, Mariam Aguas, Raquel Vicente, Mercè Navarro-Llavat, Ana Echarri, Fernando Gomollón, Elena Guerra del Río, Concepción Piñero, María José Casanova, Kateřina Špičáková, Jone Ortiz de Zárate, Emilio Torrella Cortés, Ana Gutiérrez, Horacio Alonso‐Galán, Álvaro Hernández-Martínez, José Miguel Marrero, Rufo Lorente Poyatos, Margalida Calafat, Lidia Martí Romero, Pilar Robledo, Orencio Bosch, Nuria Jiménez, María Esteve, José María Duque, Ana Fuentes Coronel, Manuela Josefa Sampedro, Eva Sesé Abizanda, Belén Herreros Martínez, Liliana Pozzati, Hipólito Fernández Rosáenz, Belén Crespo Suarez, Pilar López Serrano, Alfredo J. Lucendo, Margarita Muñoz Vicente, Fernando Bermejo, José Joaquín Ramírez Palanca, Margarita Menacho, Amalia Carmona, Raquel Camargo, Sandra Torrá Alsina, Nuria Maroto, Juan Nerín de la Puerta, Elena Castro, Ignacio Marín‐Jiménez, Belén Botella, Amparo Sapiña, Noelia Cruz, José Luis Fernández Forcelledo, Abdel Bouhmidi, Carlos Castańo-Milla, Verónica Opio, Isabel Nicolás, Marcos Kutz, A. Abraldes Bechiarelli, Jordi Gordillo, Yolanda Ber, Yolanda Torres Domínguez, María Teresa Novella Durán, Silvia Rodríguez Mondéjar, Francisco J. Martínez-Cerezo, Lilyan Kolle, M Sàbat, César Ledezma, Eduardo Iyo, Óscar Roncero, Rebeca Irisarri, Laia Lluis, Isabel Blázquez Gómez, Eva María Zapata, María José Fernández Alcalá, Cristina Martínez Pascual, María Montealegre, Laura Mata, Ana Monrobel, Alejandro Hernández-Camba, Luis Hernández, Marı́a Jesús Gómez de Tejada, Alberto Mir, María Luisa Galve, Marta Soler, Daniel Hervías, José Antonio Gómez-Valero, Manuel Barreiro‐de Acosta, Fernando Rodríguez‐Artalejo, Esther García‐Esquinas, Javier P. Gisbert,
The authors wish to make the following corrections to this paper [...].
Tópico(s): Eosinophilic Esophagitis
2022 - Multidisciplinary Digital Publishing Institute | Journal of Clinical Medicine
Ana Vázquez, Andrea Núñez Ortiz, S Rubio, María Teresa Diz-Lois Palomares, Sabino Riestra, Horacio Alonso‐Galán, E Fernández-Salgado, R Ferreiro-Iglesias, Milagros Vela, Ángel Ponferrada Díaz, Eugenia Sánchez Rodríguez, Vicent Hernández, Lara Arias García, Jesús Barrio, José María Huguet, Daniel Ginard, Montserrat Rivero, Isabel Vera Mendoza, Inmaculada Alonso-Abreu, J M Benítez, Mariam Aguas, Iago Rodríguez‐Lago, Xavier Calvet, Luís Fernández-Salazar, Ana Echarri, M Arroyo, Mercè Navarro-Llavat, Pablo Vega, Mónica Sierra, Elena Guerra del Río, Raquel Vicente, María José Casanova, Pablo Navarro, Jone Ortiz de Zárate, Pilar Varela Trastoy, Kateřina Špičáková, Ana Gutiérrez, María Dolores Martín‐Arranz, Concepción Piñero, Álvaro Hernández-Martínez, Emilio Torrella Cortés, José Miguel Marrero, R H Lorente Poyatos, Lidia Martí Romero, Orencio Bosch, José María Duque, Montserrat Aceituno, H Fernández, Belén Crespo Suarez, Ana Fuentes Coronel, Liliana Pozzati, Pilar Robledo, Eva Sesé Abizanda, Belén Herreros Martínez, Nuria Jiménez, Pilar López Serrano, Manuela Josefa Sampedro, Fernando Bermejo, Alfredo J. Lucendo, Margarita Muñoz Vicente, Margarita Menacho, José Joaquín Ramírez Palanca, Raquel Camargo, Amalia Carmona, Sandra Torrá Alsina, Margalida Calafat, José Luis Fernández Forcelledo, Juan Nerín de la Puerta, Isabel Nicolás, Verónica Opio, Yolanda Ber, Abdel Bouhmidi, A. Abraldes Bechiarelli, Carlos Castańo-Milla, Noelia Cruz, Jordi Gordillo, Amparo Sapiña, Alina López, Silvia Rodríguez Mondéjar, María Teresa Novella Durán, Belén Botella, Marcos Kutz, Lilyan Kolle, Ignacio Marín‐Jiménez, Francisco J. Martínez-Cerezo, Rebeca Irisarri, Eduardo Iyo, Óscar Roncero, M Sàbat, Yolanda Torres Domínguez, César Ledezma, Eva María Zapata, María José Fernández Alcalá, Laia Lluis, Cristina Martínez Pascual, Isabel Blázquez Gómez, Luis Hernández, Laura Mata, Ana Monrobel, Alejandro Hernández-Camba, Nuria Maroto, Marı́a Jesús Gómez de Tejada, María Luisa Galve, María Montealegre, Daniel Hervías, Marta Soler, José Antonio Gómez-Valero, Manuel Barreiro‐de Acosta, Pilar Soto Escribano, José Luis Cabriada, Daniel Ceballos, María Esteve, Alba García Rodríguez, Vanesa Royo, Fernando Gomollón, Cristina Verdejo Gil, Pilar Nos, Ruth de Francisco, María José Cuenca García, Carmen Dueñas Sadornil, Cristina Rodríguez, Beatriz Sicilia, Borja M. Fernández-Félix, J. Chaparro,
Tópico(s): Oral Health Pathology and Treatment
2025 - Elsevier BV | Gastroenterología y Hepatología